Overview

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

Status:
Enrolling by invitation

Trial end date:
2020-12-12

Target enrollment:

Participant gender:

Summary

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers under Fasting Conditions

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical